Novo Nordisk NVO has outperformed the market by 19.78% on an annualized basis over the last 5 years and has produced a compound annual return of 28.44%. Currently, Novo Nordisk has a market capitalization of $374.62 billion.

Purchase of $100 in NVO: If an investor bought $100 worth of NVO stock 5 years ago, it would be worth it $337.11 today based on a price of $168.52 for NVO at the time of writing.

Novo Nordisk’s performance over the last 5 years

Finally – what is all this? The most important takeaway to take from this article is how much of a difference compound returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.